Structures by: Shetty P.
Total: 33
<i>catena</i>-Poly[[(ethanol-κ<i>O</i>)[3-(1-phenyl-1<i>H</i>-pyrazol- 3-yl)benzoic acid-κ<i>O</i>]lithium(I)]-μ-3-(1-phenyl-1<i>H</i>-pyrazol-3-yl)benzoato- κ^2^<i>O</i>:<i>O</i>]
C34H29LiN4O5
Acta Crystallographica Section E (2009) 65, 8 m917-m918
a=7.96070(10)Å b=14.9527(2)Å c=26.5320(4)Å
α=103.4710(10)° β=90.3480(10)° γ=105.4290(10)°
5-Azido-4-benzyloxy-2-methoxy-6-methylperhydropyran-3-ol
C14H19N3O4
Acta Crystallographica Section E (2009) 65, 8 o1972
a=4.6662(2)Å b=15.3356(8)Å c=20.9273(12)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2,6-bis[(5-bromo-4,6-dimethoxypyrimidin-2-yl)oxy]benzoate
C20H18Br2N4O8
Acta Crystallographica Section E (2010) 66, 7 o1871
a=29.972(5)Å b=8.1392(12)Å c=23.061(3)Å
α=90.00° β=123.120(3)° γ=90.00°
Ethyl 1-<i>tert</i>-butyl-5-phenyl-1<i>H</i>-pyrazole-4-carboxylate
C16H20N2O2
Acta Crystallographica Section E (2010) 66, 9 o2228
a=9.0665(2)Å b=9.3351(2)Å c=10.5408(3)Å
α=110.4500(10)° β=113.9870(10)° γ=97.645(2)°
Ethyl 1,5-diphenyl-1<i>H</i>-pyrazole-4-carboxylate
C18H16N2O2
Acta Crystallographica Section E (2010) 66, 9 o2282-o2283
a=9.2015(8)Å b=10.4638(9)Å c=16.9332(15)Å
α=97.515(2)° β=104.605(2)° γ=104.578(2)°
4-(1,2,4-Triazol-1-yl)aniline
C8H8N4
Acta Crystallographica Section E (2011) 67, 1 o164
a=5.54880(10)Å b=7.3656(2)Å c=19.5477(5)Å
α=90.00° β=99.416(2)° γ=90.00°
5-[(4-Methoxybenzyl)sulfanyl]-2-methyl-1,3,4-thiadiazole
C11H12N2OS2
Acta Crystallographica Section E (2011) 67, 1 o163
a=14.7765(4)Å b=8.6916(3)Å c=9.7339(3)Å
α=90.00° β=96.4770(10)° γ=90.00°
2-Methyl-5-[(3-methyl-4-nitrobenzyl)sulfanyl]-1,3,4-thiadiazole
C11H11N3O2S2
Acta Crystallographica Section E (2011) 67, 1 o205-o206
a=13.8210(14)Å b=4.5720(5)Å c=19.7929(19)Å
α=90.00° β=90.00° γ=90.00°
2-Phenoxyacetohydrazide
C8H10N2O2
Acta Crystallographica Section E (2010) 66, 1 o53-o54
a=6.3397(8)Å b=4.0590(6)Å c=15.948(2)Å
α=90.00° β=99.218(10)° γ=90.00°
2-(2-Chlorophenoxy)acetohydrazide
C8H9ClN2O2
Acta Crystallographica Section E (2010) 66, 1 o31-o32
a=15.2384(5)Å b=3.92690(10)Å c=16.8843(6)Å
α=90.00° β=117.269(2)° γ=90.00°
<i>N</i>-(1-Naphthyl)-10<i>H</i>-9-oxa-1,3-diazaanthracen-4-amine
C21H15N3O
Acta Crystallographica Section E (2009) 65, 3 o523-o524
a=13.2762(3)Å b=8.8700(2)Å c=27.1997(5)Å
α=90.00° β=90.00° γ=90.00°
2-[(4-<i>tert</i>-Butylanilino)(phenyl)methyl]cyclohexanone
C23H29NO
Acta Crystallographica Section E (2009) 65, 3 o539-o540
a=6.5315(2)Å b=12.3946(3)Å c=12.8853(3)Å
α=62.9730(10)° β=86.347(2)° γ=85.103(2)°
Methyl 3,4-<i>O</i>-isopropylidene-β-D—– fucopyranoside monohydrate
C10H18O5,H2O
Acta Crystallographica Section E (2009) 65, 5 o1002-o1003
a=8.58240(10)Å b=9.28340(10)Å c=14.6711(2)Å
α=90.00° β=90.00° γ=90.00°
(4-Chloro-2-fluorophenyl)[1-(2,6-difluorophenyl)but-3-enyl]amine
C16H13ClF3N
Acta Crystallographica Section E (2009) 65, 5 o1027-o1028
a=10.89800(10)Å b=14.0073(2)Å c=10.16510(10)Å
α=90.00° β=113.0180(10)° γ=90.00°
4-(4-Fluorophenoxy)benzoic acid
C13H9FO3
Acta Crystallographica Section E (2009) 65, 8 o1971
a=5.88500(10)Å b=7.8526(2)Å c=12.0250(2)Å
α=91.8030(10)° β=96.3210(10)° γ=106.0270(10)°
6-deoxy-6-iodo-1,2:3,4-di-<i>O</i>-isopropylidene-α-D-galactopyranoside
C12H19IO5
Acta Crystallographica Section E (2009) 65, 8 o1999-o2000
a=7.35950(10)Å b=11.5145(2)Å c=16.9945(2)Å
α=90° β=90° γ=90°
3-(2,4-Dichlorophenyl)-5-methyl-1,2,4-oxadiazole
C9H6Cl2N2O
Acta Crystallographica Section E (2010) 66, 4 o772
a=3.8252(7)Å b=21.678(4)Å c=11.0833(19)Å
α=90.00° β=92.421(4)° γ=90.00°
3-(2,4-Dichlorophenyl)-5-phenyl-1,2,4-oxadiazole
C14H8Cl2N2O
Acta Crystallographica Section E (2010) 66, 4 o851
a=3.8035(2)Å b=10.9666(7)Å c=14.6949(9)Å
α=99.044(2)° β=91.158(2)° γ=98.891(2)°
5-(2,4-Dichlorophenyl)-3-(4-nitrophenyl)-1,2,4-oxadiazole
C14H7Cl2N3O3
Acta Crystallographica Section E (2010) 66, 5 o1196-o1197
a=13.5272(5)Å b=6.5362(2)Å c=15.6880(5)Å
α=90.00° β=90.00° γ=90.00°
2-Chloro-4-nitro-1<i>H</i>-imidazole
C3H2ClN3O2
Acta Crystallographica Section E (2010) 66, 7 o1828-o1829
a=5.905(2)Å b=10.033(4)Å c=9.150(3)Å
α=90.00° β=105.180(8)° γ=90.00°
Methyl 2,6-bis[(5-chloro-4,6-dimethoxypyrimidin-2-yl)oxy]benzoate
C20H18Cl2N4O8
Acta Crystallographica Section E (2010) 66, 7 o1869-o1870
a=29.354(3)Å b=8.0485(8)Å c=22.5923(19)Å
α=90.00° β=123.014(2)° γ=90.00°
4,6-Dimethoxy-2-(methylsulfonyl)pyrimidine
C7H10N2O4S
Acta Crystallographica Section E (2010) 66, 8 o1913
a=8.349(2)Å b=11.067(3)Å c=11.438(3)Å
α=108.457(8)° β=92.774(8)° γ=98.504(8)°
4-(<i>o</i>-Tolyl)piperazin-1-ium chloride
C11H17N2,Cl
Acta Crystallographica Section E (2011) 67, 11 o3115
a=8.1572(2)Å b=11.2821(3)Å c=12.4256(3)Å
α=90.00° β=90.00° γ=90.00°
2,6-Dichloro-3-nitropyridine
C5H2Cl2N2O2
Acta Crystallographica Section E (2011) 67, 7 o1785
a=7.9021(8)Å b=19.166(2)Å c=11.0987(9)Å
α=90.00° β=122.072(5)° γ=90.00°
Methyl 2-[(2-methylphenoxy)methyl]benzoate
C16H16O3
Acta Crystallographica Section E (2012) 68, 3 o728
a=31.6873(13)Å b=6.5389(2)Å c=13.8746(6)Å
α=90.00° β=111.716(2)° γ=90.00°
2-(5-Bromopyridin-3-yl)-5-[3-(4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine- 5-ylsulfonyl)thiophen-2-yl]-1,3,4-oxadiazole
C18H13BrN4O3S3
Acta Crystallographica Section E (2011) 67, 10 o2743-o2744
a=7.0327(14)Å b=7.6488(15)Å c=36.939(7)Å
α=90.00° β=91.315(5)° γ=90.00°
2-(Biphenyl-4-yl)-5-[3-(4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine- 5-ylsulfonyl)thiophen-2-yl]-1,3,4-oxadiazole
C25H19N3O3S3
Acta Crystallographica Section E (2011) 67, 10 o2781-o2782
a=7.91080(10)Å b=12.09430(10)Å c=12.9498(2)Å
α=69.2530(10)° β=76.7940(10)° γ=77.4600(10)°
4-(3-Chlorophenyl)-3-[(2,6-difluorobenzyl)sulfanyl]-5-(3,4,5- trimethoxyphenyl)-4<i>H</i>-1,2,4-triazole
C24H20ClF2N3O3S
Acta Crystallographica Section E (2011) 67, 12 o3422-o3423
a=9.9867(2)Å b=21.5140(3)Å c=11.9793(2)Å
α=90.00° β=117.1970(10)° γ=90.00°
1-Cyclohexyl-5-(4-methoxyphenyl)-1<i>H</i>-pyrazole-4-carboxylic acid
C17H20N2O3
Acta Crystallographica Section E (2011) 67, 12 o3513
a=12.0722(9)Å b=12.7180(9)Å c=11.7739(8)Å
α=90.00° β=118.6980(10)° γ=90.00°
Ethyl 1-cyclohexyl-5-(4-methoxyphenyl)-1<i>H</i>-pyrazole-4-carboxylate
C19H24N2O3
Acta Crystallographica Section E (2011) 67, 12 o3460-o3461
a=6.8959(7)Å b=11.0858(7)Å c=12.0142(12)Å
α=100.690(2)° β=93.1070(10)° γ=95.3540(10)°
4-(4-Bromophenyl)-1-(2,6-difluorobenzyl)-3-(3,4,5-trimethoxyphenyl)-1<i>H</i>- 1,2,4-triazole-5(4<i>H</i>)-thione
C24H20BrF2N3O3S
Acta Crystallographica Section E (2012) 68, 1 o89
a=17.6694(18)Å b=15.5299(16)Å c=18.0855(19)Å
α=90.00° β=102.955(2)° γ=90.00°
1-[(3-Benzyloxy-2-nitrophenoxy)methyl]benzene
C20H17NO4
Acta Crystallographica Section E (2012) 68, 8 o2317-o2318
a=7.6150(4)Å b=14.6248(7)Å c=15.2915(8)Å
α=94.7060(10)° β=101.6270(10)° γ=90.5720(10)°
3-Aminoquinoline
C9H8N2
Acta Crystallographica Section E (2012) 68, 11 o3155
a=7.6223(3)Å b=7.6289(3)Å c=12.6967(4)Å
α=90.00° β=90.00° γ=90.00°